First Time Loading...

Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD
Updated: May 6, 2024

Horizon Therapeutics PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Horizon Therapeutics PLC
Operating Income Peer Comparison

Comparables:
ALKS
AMRN
PRTA
M
MURA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Horizon Therapeutics PLC
NASDAQ:HZNP
Operating Income
$567.6m
CAGR 3-Years
66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alkermes Plc
NASDAQ:ALKS
Operating Income
$420.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
28%
Amarin Corporation PLC
NASDAQ:AMRN
Operating Income
-$26m
CAGR 3-Years
N/A
CAGR 5-Years
25%
CAGR 10-Years
16%
Prothena Corporation PLC
NASDAQ:PRTA
Operating Income
-$191m
CAGR 3-Years
-19%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
M
Mural Oncology PLC
NASDAQ:MURA
Operating Income
-$196.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Horizon Therapeutics PLC's Operating Income?
Operating Income
567.6m USD

Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Operating Income amounts to 567.6m USD.

What is Horizon Therapeutics PLC's Operating Income growth rate?
Operating Income CAGR 3Y
66%

Over the last year, the Operating Income growth was -37%. The average annual Operating Income growth rates for Horizon Therapeutics PLC have been 66% over the past three years .